BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26334045)

  • 1. Cancer Metastasis: Perivascular Macrophages Under Watch.
    Kadioglu E; De Palma M
    Cancer Discov; 2015 Sep; 5(9):906-8. PubMed ID: 26334045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA.
    Harney AS; Arwert EN; Entenberg D; Wang Y; Guo P; Qian BZ; Oktay MH; Pollard JW; Jones JG; Condeelis JS
    Cancer Discov; 2015 Sep; 5(9):932-43. PubMed ID: 26269515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tie2 Expression on Macrophages Is Required for Blood Vessel Reconstruction and Tumor Relapse after Chemotherapy.
    Chen L; Li J; Wang F; Dai C; Wu F; Liu X; Li T; Glauben R; Zhang Y; Nie G; He Y; Qin Z
    Cancer Res; 2016 Dec; 76(23):6828-6838. PubMed ID: 27758887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are TEMs Canceled? Questioning the Functional Relevance of Tie2-Expressing Macrophages.
    Zhang Y; Brekken RA
    Cancer Res; 2022 Apr; 82(7):1172-1173. PubMed ID: 35373288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability.
    Peters S; Cree IA; Alexander R; Turowski P; Ockrim Z; Patel J; Boyd SR; Joussen AM; Ziemssen F; Hykin PG; Moss SE
    Cytokine; 2007 Nov; 40(2):144-50. PubMed ID: 17959386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietin-2/Tie2 signaling involved in TNF-α induced peritoneal angiogenesis.
    Yuan J; Fang W; Lin A; Ni Z; Qian J
    Int J Artif Organs; 2012 Sep; 35(9):655-62. PubMed ID: 23065888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and metastasis establishment.
    Holopainen T; Huang H; Chen C; Kim KE; Zhang L; Zhou F; Han W; Li C; Yu J; Wu J; Koh GY; Alitalo K; He Y
    Cancer Res; 2009 Jun; 69(11):4656-64. PubMed ID: 19487284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke.
    Zacharek A; Chen J; Cui X; Li A; Li Y; Roberts C; Feng Y; Gao Q; Chopp M
    J Cereb Blood Flow Metab; 2007 Oct; 27(10):1684-91. PubMed ID: 17356562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.
    Singh H; Milner CS; Aguilar Hernandez MM; Patel N; Brindle NP
    Cell Signal; 2009 Aug; 21(8):1346-50. PubMed ID: 19376222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via Src dependent pathway in retinal endothelial cells.
    Kalishwaralal K; Sheikpranbabu S; BarathManiKanth S; Haribalaganesh R; Ramkumarpandian S; Gurunathan S
    Angiogenesis; 2011 Mar; 14(1):29-45. PubMed ID: 21061058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production.
    Huang YH; Wu MP; Pan SC; Su WC; Chen YW; Wu LW
    Angiogenesis; 2013 Jan; 16(1):207-22. PubMed ID: 23086340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigment epithelium-derived factor inhibits vascular endothelial growth factor-and interleukin-1beta-induced vascular permeability and angiogenesis in retinal endothelial cells.
    Sheikpranbabu S; Ravinarayanan H; Elayappan B; Jongsun P; Gurunathan S
    Vascul Pharmacol; 2010; 52(1-2):84-94. PubMed ID: 20006737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.
    Takeda N; Maemura K; Imai Y; Harada T; Kawanami D; Nojiri T; Manabe I; Nagai R
    Circ Res; 2004 Jul; 95(2):146-53. PubMed ID: 15192019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor-angiopoietin chimera with improved properties for therapeutic angiogenesis.
    Anisimov A; Tvorogov D; Alitalo A; Leppänen VM; An Y; Han EC; Orsenigo F; Gaál EI; Holopainen T; Koh YJ; Tammela T; Korpisalo P; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Dejana E; Koh GY; Choi C; Saharinen P; Alitalo K
    Circulation; 2013 Jan; 127(4):424-34. PubMed ID: 23357661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.
    Coffelt SB; Tal AO; Scholz A; De Palma M; Patel S; Urbich C; Biswas SK; Murdoch C; Plate KH; Reiss Y; Lewis CE
    Cancer Res; 2010 Jul; 70(13):5270-80. PubMed ID: 20530679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
    Chen HM; Tsai CH; Hung WC
    Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide from the extracellular region of the synaptic protein α Neurexin stimulates angiogenesis and the vascular specific tyrosine kinase Tie2.
    Graziano S; Marchiò S; Bussolino F; Arese M
    Biochem Biophys Res Commun; 2013 Mar; 432(4):574-9. PubMed ID: 23485462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.
    Daly C; Eichten A; Castanaro C; Pasnikowski E; Adler A; Lalani AS; Papadopoulos N; Kyle AH; Minchinton AI; Yancopoulos GD; Thurston G
    Cancer Res; 2013 Jan; 73(1):108-18. PubMed ID: 23149917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
    Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability.
    Cao R; Eriksson A; Kubo H; Alitalo K; Cao Y; Thyberg J
    Circ Res; 2004 Mar; 94(5):664-70. PubMed ID: 14739162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.